StreetAlpha
13F holdings · Q3 2026

Deerfield Management Company

New York, NY · files as Deerfield Management Company, L.P.
Know the moment Deerfield Management Company filesYou follow Deerfield Management Company An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1009258

Deerfield Management Company reported 67 stocks worth $5.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.5%), CNC (5.9%) and UTHR (5.7%). Compared with Q2 2026, the fund opened new positions in ZTS, COO and BLSM, added to UTHR, COGT and CELC, trimmed RVMD, VTRS and NAMS and sold out of LNTH, PFE and INDV.

Latest filing: what Deerfield Management Company did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
7 new11 added13 trimmed12 sold outBought about $545M · sold about $2.9B
New 7
See all 7 →
Added 11
See all 11 →
Trimmed 13
See all 13 →
Sold out 12
See all 12 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$5.1B−36.2% vs last quarter
Stocks held677 new · 12 sold out
Top 5 weight30.4%spread out
Turnover68%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
RVMD
Revolution Medicines Inc
$436M8.5%2.1M−268K (−11%)8 of 8
2
CNC
Centene Corp Del
$304M5.9%4.9MNo change8 of 8
3
UTHR
United Therapeutics Corp Del
$293M5.7%541K+84K (+18%)7 of 8
4
PRAX
Praxis Precision Medicines I
$281M5.5%963KNo change7 of 8
5
GMAB
Genmab A/s
$245M4.8%6.9MNo change3 of 8
6
VTRS
Viatris Inc
$194M3.8%10.9M−9.3M (−46%)8 of 8
7
COGT
Cogent Biosciences Inc
$191M3.7%6M+951K (+19%)8 of 8
8
CELC
Celcuity Inc
$191M3.7%2.4M+947K (+65%)5 of 8
9
LEGN
Legend Biotech Corp
$162M3.2%8.1MNo change8 of 8
10
VERA
Vera Therapeutics Inc
$140M2.7%4.3M+422K (+11%)7 of 8
🔒 57 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
NUVALENT INC
$2.1B17.2M
LNTH
Lantheus Hldgs Inc
$83.5M753K
PFE
Pfizer Inc
$73.2M3M
INDV
Indivior PLC
$67.7M1.6M
CDNA
Caredx Inc
$56.9M2M

🔒 Free account: see all 12.

Reported value

last 8 quarters
$4.7BQ4 '24
$4.4BQ1 '25
$4.9BQ2 '25
$6BQ3 '25
$6.8BQ4 '25
$7.2BQ1 '26
$8BQ2 '26
$5.1BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Deerfield Management Company 13F FAQ

What does Deerfield Management Company own?

Deerfield Management Company reported 67 stocks worth $5.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (8.5%), CNC (5.9%) and UTHR (5.7%). The table above lists every position in the filing (the top 10 without an account).

What did Deerfield Management Company buy and sell in Q3 2026?

Compared with Q2 2026: 7 new positions, 11 added to, 13 trimmed and 12 sold out. New positions include ZTS, COO and BLSM. It sold all of LNTH, PFE and INDV.

When will Deerfield Management Company file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Deerfield Management Company's portfolio worth?

The Q3 2026 filing reports $5.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.